Skip to content

Total Revenue at other companies

Amgen logo
AmgenAMGN
$8.62B+5.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$3.61B+19.0%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$2M+37.2%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$0
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$25.56M-8.0%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$17.7M+15.0%

Other financials

Income statement

See full
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Operating margin-5,176.5%+1,764pp
Net margin-4,719%+2,752pp

Returns & leverage

See full
Return on equity-41.8%
Debt / equity0.0×
Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s total revenue?
Upstream Bio, Inc. (UPB) reported total revenue of $1.03M in Q1 2026.
How has Upstream Bio, Inc.'s total revenue changed year-over-year?
Upstream Bio, Inc.'s total revenue increased by 82.7% year-over-year, from $566K to $1.03M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.